Sign In

James Davie

President/ CEO at MalarVx

Professional Background

James Davie is an accomplished biotechnology and pharmaceutical leader with over 30 years of extensive experience in the industry. Throughout his illustrious career, he has successfully launched five companies and played pivotal roles in commercial product development, achieving remarkable financial success with three products generating annual revenues exceeding $1 billion. His entrepreneurial spirit and innovative mindset have not only led to business growth but have also made significant contributions to global health initiatives.

In his role as President and CEO of MalarVx, a company he founded in 2012, James is at the forefront of the fight against malaria. MalarVx is dedicated to commercializing groundbreaking research that has culminated in the development of a genetically-attenuated P. falciparum-based vaccine. This initiative reflects James's commitment to utilizing scientific advancements for global health improvements, especially in eradicating one of the world’s leading infectious diseases.

Prior to his role at MalarVx, James served as President and CEO at AttoDx, Inc., where he oversaw the development of diagnostic solutions that have had significant impacts on patient care. Additionally, he held the position of President at Blood Cell Storage, Inc., contributing to advancements in biopreservation technology that enhance the storage and usability of blood products for medical applications.

With a strong emphasis on research, James has dedicated over 20 years to serving on the board of directors for the Center for Infectious Disease Research in Seattle, WA, formerly known as Seattle Biomed. His involvement with this prestigious organization illustrates his commitment to advancing global health research and supporting initiatives aimed at combating infectious diseases.

Education and Achievements

James Davie holds a Bachelor of Arts degree in Biochemistry from Pomona College, where he laid the foundation for his scientific expertise. Following this, he pursued a Master of Science in Industrial Administration from Carnegie Mellon University’s Tepper School of Business, equipping him with a robust understanding of business management and strategic decision-making in the biotechnology sector.

Throughout his career, James has demonstrated a remarkable ability to blend scientific innovation with commercial strategy. His entrepreneurial journey has been marked by two successful exits, highlighting his knack for building companies that not only thrive but also provide exceptional returns for investors and stakeholders.

James's achievements are not just confined to business; his work in developing a vaccine designed to combat malaria positions him as a leader in public health. The implications of his work are profound, aiming to save lives and improve health outcomes in regions severely affected by malaria.

Notable Contributions

  1. Successful Company Launches: James has established five companies, two of which have seen exceptional success with notable exits. His strategic foresight and innovative approaches have created substantial valuation increases, including a remarkable 100X exit.
  2. Global Health Advocacy: As a dedicated board member of the Center for Infectious Disease Research, James has played a crucial role in guiding research efforts to combat infectious diseases globally. His work emphasizes the importance of scientific research in addressing public health challenges.
  3. Vaccine Development: Committed to the fight against malaria, James launched MalarVx, aiming to commercialize the first-ever genetically-attenuated vaccine against P. falciparum. This vaccine holds promise in reducing malaria incidence and mortality rates, reflecting James's dedication to impactful scientific research.
  4. Industry Leadership: Having held key positions at innovative companies, including AttoDx, Inc. and Blood Cell Storage, Inc., James has contributed significantly to advancements in medical diagnostics and blood product preservation, showcasing his versatility and expertise in biotechnology and pharmaceuticals.

Related Questions

How did James Davie develop his expertise in biotechnology and pharmaceuticals?
What inspired James Davie to found MalarVx and focus on malaria vaccine development?
Can James Davie share insights on his experience launching five companies in the biotech sector?
What have been the biggest challenges and achievements in James Davie's career?
How has James Davie's education at Pomona College and Carnegie Mellon University influenced his professional journey?
James Davie
Add to my network

Location

Greater Seattle Area